Health officials launch clinical trial reforms to counter China threat

Why this matters: political developments that affect policy direction and public trust.

The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of an effort to reduce development timelines and reverse a growing trend of companies moving overseas, primarily to China. The pilot program, part of a broader initiative across